Extemporaneous Formulations

for Pediatric, Geriatric, and Special Needs Patients

Restricted access
Buy Book in ASHP Store

List Price: $124.00 

Member Price: $95.00

Page Count: 392

Since its first publication, Extemporaneous Formulations has been the go-to guide for treating patients who require medications that are not commercially available in appropriate forms or dosages for pediatric, geriatric, or special needs. 

Now even more comprehensive, the fourth edition provides the same evidence-based formulation in easy-to-follow “recipes” for 312 formulations, 129 of which are new.

NOTE: The link below allows you to download the ePub file. If you want the PDF files, click on Table of Contents, browse the chapters by clicking on the drop-down symbol ^, select a chapter, and you will see the DOWNLOAD PDF orange button in the upper right. Most ePub files can be opened in eBook readers, like the B&N Nook and Kobo eReader. These files have to be converted to .Mobi format before they are usable on the Amazon Kindle device or app. For your computer, the easiest way to open an ePub file is to double-click on it and let your PC decide which default application should open the file. If no program opens it, then you probably do not have an application installed that can view ePub files. ePub files can also be opened on a computer with various free programs including Adobe Digital Editions. If you have access to this title you can download the ePub here:

    • Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients (EPUB 955 KB)
    • Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients (PDF 1.89 MB)

Since its first publication in 2003, Extemporaneous Formulations has been the go-to guide for treating pediatric, geriatric, and special needs patients who require medications that are not commercially available in appropriate forms or dosages. This new edition contains a total of 312 formulations—triple the number included in the first edition. The content included in this edition is based on a comprehensive literature search to identify new drugs with extemporaneous formulations and new formulations of drugs that are in the previous editions. This effort resulted in 129 new formulations, 47 of which are new drugs and 36 of which are new concentrations of drugs that were in the previous edition. New content fields were also added to reflect potential upcoming changes to United States Pharmacopoeia (USP) General Chapter <795>.

Each formulation in this edition includes:

  • Ingredients
  • Equipment and Supplies
  • Preparation Details
  • Special Instructions
  • Alternatives
  • Quality-Control Procedures
  • Labeling Requirements
  • Storage Conditions/Stability
  • Stability Study Details
  • References

An invaluable resource for practitioners, Extemporaneous Formulations also includes a list of standardized concentrations for compounded oral liquids from ASHP’s Standardize 4 Safety initiative.

 

Rita K. Jew, PharmD, MBA, BCPPS, FASHP

Rita K. Jew is President at the Institute for Safe Medication Practices (ISMP). She has more than 30 years of experience leading pharmaceutical care services. Prior to joining ISMP, she served as Principal of RKJ Health Partners, where she provided consulting services related to medication safety, pharmacy operations, pharmacy finance, specialty pharmacy, and sterile compounding. She also provided coaching and leadership training and advised technology start-ups. Before starting her own consulting business, Dr. Jew held leadership positions at well-known acute care institutions, including University of California San Francisco (UCSF) Health, Children’s Hospital of Orange County, and Children’s Hospital of Philadelphia.

Dr. Jew received her Doctor of Pharmacy from University of California at San Francisco, completed an ASHP-accredited residency in clinical pharmacy at Thomas Jefferson University Hospital, and earned a MBA from the Wharton School of the University of Pennsylvania. She is a board-certified pediatric pharmacy specialist. 

Dr. Jew has published and presented on a wide range of issues. She has held leadership positions at local, state, and national pharmacy organizations, serving as Chair of the Executive Committee of the Section of Clinical Specialists and Scientists (SCSS) at ASHP, Director-at-Large of the Pennsylvania Society of Health-System Pharmacists Board, and President of the Delaware Valley Society of Health-System Pharmacists (DVSHP). Her many honors and awards include a Children’s Hospital Association Honorable Mention in the Race for Results for improving patient safety by optimizing smart pump utilization, Friend of Nursing Award from the Association of California Nurse Leaders, Distinguished Service Award from ASHP’s SCSS, and the Jonathan Roberts Award from DVSHP.

 

Winson Soo-Hoo, RPh, MBA

Winson Soo-Hoo is Senior Director of the Department of Pharmacy at The Children’s Hospital of Philadelphia, PA, since 1990, and a Residency Preceptor with the pharmacy residency program. He received his Bachelor of Science in Pharmacy from the Philadelphia College of Pharmacy & Science, Philadelphia, and his MBA at Drexel University. He routinely consults with healthcare institutions on pediatric pharmacy systems and service. 

Soo-Hoo has lectured at various forums on controlled substance security and diversion programs, lean management principles, and pharmacy automation and technology-IV robot technology. He received the Innovation and Collaborative Practice Award from the Pennsylvania Society of Health-System Pharmacists in 1998.

 

Elham Amiri, BS, CPhT

Elham Amiri is a Technician Supervisor in the Department of Pharmaceutical Services at UCSF Medical Center at Mission Bay. She received a BS from San Francisco State University, with an emphasis in physiology, and earned a national certification from PTCB. Ms. Amiri has 18 years of experience in healthcare and the pharmaceutical industry with a wide scope of specialties including inpatient, retail, and biotechnology.  Her healthcare experience is enhanced by a background in human resources stemming from involvement with two international start-up companies, and she has obtained her Human Resources Management Certification from Employers Group. 

At UCSF Medical Center, Ms. Amiri is a project manager, particularly in the areas of pediatrics and sterile and non-sterile compounding. She is involved in personnel training emphasizing USP <797>, standard work review, and quality improvement initiatives.  She establishes and performs operational evaluations and was heavily involved in operationalizing pharmaceutical services at the newly opened UCSF Medical Center at Mission Bay, including Benioff Children’s Hospital. Alongside her project management responsibilities, Ms. Amiri has oversight of all technician staff at the Mission Bay Campus.

 

Jamie M. Gomes, PharmD, BCPS

Jamie M. Gomes is a Residency Preceptor with the Pharmacy Residency Program, and the Medication Order Review Process Supervisor at Children's Hospital of Philadelphia (CHOP). She earned her PharmD from Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey, Piscataway, New Jersey. Dr. Gomes completed a PGY1 pharmacy practice residency at the Peninsula Regional Medical Center, Salisbury, Maryland, and a PGY2 drug information specialty at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.

Prior to her current role, Dr. Gomes was a Clinical Pharmacy Specialist in Drug Information and Clinical Informatics at CHOP. She was involved with drug information services, clinical decision support committee, and medication safety. She managed pharmacy-driven changes to the electronic health record and maintained the smart pump libraries at CHOP.

“This exceptional, high-quality reference is crucial for those who perform extemporaneous compounding as this specialized area of pharmacy continues to evolve. It stands alone in its completeness and accuracy.” 

Jennifer L. Colon, PharmD, MS, MBA